Ahmed Mohammed Elnour Elkhalifa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ahmed Mohammed Elnour Elkhalifa has a total of 189 co-authors. Here are the top co-authors by number of shared publications:
- Abozer Y. Elderdery
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia
12 shared publications - Mohammed Abdulwahid Almorish
Department of Hematology, Faculty of Medicine and Health Sciences, Sana’a University, Sana’a, Yemen
10 shared publications - Showkat Ul Nabi
Preclinical Research Laboratory, Department of Clinical Veterinary Medicine, Ethics & Jurisprudence, Sher-e-Kashmir University of Agricultural Sciences and Technology (SKUAST-Kashmir), Srinagar, J&K, 190006, India
6 shared publications - Nasser A. N. Alzerwi
Department of Surgery, College of Medicine, Majmaah University, Al-Majmaah 11952, Saudi Arabia
5 shared publications - Pooi Ling Mok
Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia
5 shared publications - Abdelhakam Gammar Tamomh
Department of Parasitology and Medical Entomology, Faculty of Medical Laboratory Sciences, University of El Imam El Mahdi, Kosti, Sudan
4 shared publications
Latest Publications
- 24 May 2026
- Published by Springer Nature in Current Microbiology
- Vol. 83 (7) , 379
Prevalence of Hepatitis B virus Genotypes and their Correlation with Serological Markers among Chronic Infected Patients in Sudan
Hepatitis B virus (HBV) represents a significant global health issue, associated with elevated morbidity and mortality rates, particularly in African regions like Sudan, necessitating data on the prevalence of HBV genotypes and related biomarkers to enhance local and national prevention and control measures. This research aimed to clarify the frequency of HBV genotypes in chronic patients and their association with serological markers in four states of Sudan. A cross-sectional study was performed from December 2020 to February 2022 in Sudan. Among 385 patients positive for HBV, 200 were identified as chronic cases. Genotyping and viral load assessments via Polymerase Chain Reaction (PCR) and the INNO-LiPA techniques. Virological markers were evaluated using a standardized enzyme-linked immunosorbent assay (ELISA). Of the 385 patients with HBV in this study, 84.2% were male and 15.8% female, with 2.9% co-infected with HIV. A cohort of 200 individuals diagnosed with chronic HBV infection met the eligibility criteria. The prevalence of HBV genotype D was recorded at 92.5%, followed by the mixed genotype A/D at 4.5% and genotype A at 3.0%. Chronic HBV patients with D genotype exhibited normal liver enzyme levels, indicating a significant correlation with liver enzymes. Most negative hepatitis B envelope antigen (HBeAg) and positive HIV co-infection patients exhibited chronic HBV of the D genotype. The dominant genotype identified among patients with chronic HBV was genotype D, associated with higher HBeAg negativity, viral DNA loads of ≥ 10^3 copies/ml, normal liver enzyme activity, and concurrent HIV infection.
- 24 May 2026
- Published by Springer Nature in Current Microbiology
- Vol. 83 (7) , 379
Prevalence of Hepatitis B virus Genotypes and their Correlation with Serological Markers among Chronic Infected Patients in Sudan
Hepatitis B virus (HBV) represents a significant global health issue, associated with elevated morbidity and mortality rates, particularly in African regions like Sudan, necessitating data on the prevalence of HBV genotypes and related biomarkers to enhance local and national prevention and control measures. This research aimed to clarify the frequency of HBV genotypes in chronic patients and their association with serological markers in four states of Sudan. A cross-sectional study was performed from December 2020 to February 2022 in Sudan. Among 385 patients positive for HBV, 200 were identified as chronic cases. Genotyping and viral load assessments via Polymerase Chain Reaction (PCR) and the INNO-LiPA techniques. Virological markers were evaluated using a standardized enzyme-linked immunosorbent assay (ELISA). Of the 385 patients with HBV in this study, 84.2% were male and 15.8% female, with 2.9% co-infected with HIV. A cohort of 200 individuals diagnosed with chronic HBV infection met the eligibility criteria. The prevalence of HBV genotype D was recorded at 92.5%, followed by the mixed genotype A/D at 4.5% and genotype A at 3.0%. Chronic HBV patients with D genotype exhibited normal liver enzyme levels, indicating a significant correlation with liver enzymes. Most negative hepatitis B envelope antigen (HBeAg) and positive HIV co-infection patients exhibited chronic HBV of the D genotype. The dominant genotype identified among patients with chronic HBV was genotype D, associated with higher HBeAg negativity, viral DNA loads of ≥ 10^3 copies/ml, normal liver enzyme activity, and concurrent HIV infection.
- Open Access
- 23 December 2025
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 16 (1)
Assessing Knowledge and Attitudes Regarding Celiac Disease and gluten-free Products Among Healthy Blood Donors: A Cross-Sectional Study
Background Celiac disease (CD) is an autoimmune condition marked by intestinal mucosa inflammation due to gluten. Currently, the sole effective treatment for CD is a gluten-free diet. knowledge and attitudes towards CD are essential for timely diagnosis and management. This research seeks to explore the knowledge and attitudes of blood donors regarding CD and gluten-free products in Yemen. Methods A cross-sectional study was executed involving 216 healthy male blood donors in Sana’a, Yemen. The questionnaire used in the study was a reliable survey instrument (with a Cronbach’s alpha coefficient of 0.71) employed for the purpose of data collection. Demographic information, knowledge, and attitudes regarding CD were gathered through direct questionnaire administration. The questionnaire was divided into three parts: (1) demographic questions on age, sex, marital status, education level, blood groups, and body mass index (BMI); (2) knowledge assessment with 10 items; and (3) an attitude section with 4 questions. Statistical analysis utilized SPSS version 24 (IBM Chicago, IL, USA). Results A total of 216 blood donors were analysed. All participants were male, aged between 20 and 52 years. Among the participants, 14.8% exhibited familiarity with CD and gluten-free products. A comprehensive analysis revealed that 3.7% of participants possessed sufficient knowledge, 11.1% exhibited moderate knowledge, whereas 85.2% indicated a lack of knowledge regarding CD and gluten-free products. The vast majority 99.1% of participants demonstrated unfavourable attitudes towards CD and gluten-free products. A significant weak positive correlation was identified between knowledge scores and attitudes towards CD and gluten-free products (r = 0.370, P < 0.001). No correlation was found between socio-demographic factors and blood donors’ knowledge and attitudes regarding CD and gluten-free products. Conclusion The research revealed a significant lack of awareness and ongoing misconceptions regarding CD within the Yemeni population. These results highlight the critical necessity for focused educational initiatives and enhanced availability of gluten-free products to promote timely diagnosis and efficient disease management.
- 23 December 2025
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 16 (1)
Open AccessAssessing Knowledge and Attitudes Regarding Celiac Disease and gluten-free Products Among Healthy Blood Donors: A Cross-Sectional Study
Background Celiac disease (CD) is an autoimmune condition marked by intestinal mucosa inflammation due to gluten. Currently, the sole effective treatment for CD is a gluten-free diet. knowledge and attitudes towards CD are essential for timely diagnosis and management. This research seeks to explore the knowledge and attitudes of blood donors regarding CD and gluten-free products in Yemen. Methods A cross-sectional study was executed involving 216 healthy male blood donors in Sana’a, Yemen. The questionnaire used in the study was a reliable survey instrument (with a Cronbach’s alpha coefficient of 0.71) employed for the purpose of data collection. Demographic information, knowledge, and attitudes regarding CD were gathered through direct questionnaire administration. The questionnaire was divided into three parts: (1) demographic questions on age, sex, marital status, education level, blood groups, and body mass index (BMI); (2) knowledge assessment with 10 items; and (3) an attitude section with 4 questions. Statistical analysis utilized SPSS version 24 (IBM Chicago, IL, USA). Results A total of 216 blood donors were analysed. All participants were male, aged between 20 and 52 years. Among the participants, 14.8% exhibited familiarity with CD and gluten-free products. A comprehensive analysis revealed that 3.7% of participants possessed sufficient knowledge, 11.1% exhibited moderate knowledge, whereas 85.2% indicated a lack of knowledge regarding CD and gluten-free products. The vast majority 99.1% of participants demonstrated unfavourable attitudes towards CD and gluten-free products. A significant weak positive correlation was identified between knowledge scores and attitudes towards CD and gluten-free products (r = 0.370, P < 0.001). No correlation was found between socio-demographic factors and blood donors’ knowledge and attitudes regarding CD and gluten-free products. Conclusion The research revealed a significant lack of awareness and ongoing misconceptions regarding CD within the Yemeni population. These results highlight the critical necessity for focused educational initiatives and enhanced availability of gluten-free products to promote timely diagnosis and efficient disease management.
- Open Access
- 8 December 2025
- Published by Springer Nature in Thrombosis Journal
- Vol. 23 (1) , 117
The correlation of lupus anticoagulant and anticardiolipin antibodies with hematological parameters and clinical findings in sickle cell disease at steady state phase
Current therapeutic interventions for Sickle Cell Disease (SCD) have improved patient survival; however, the clinical determinants of elevated autoantibody prevalence and related complications in patients with SCD remain insufficiently elucidated. This study aimed to examine the frequency of lupus anticoagulant (LA), anticardiolipin antibody (aCL), and anti-beta2 glycoprotein I antibodies (anti- β2GPI) in patients with SCD at steady state phase to evaluate their possible correlations with hematological factors and clinical complications. This cross-sectional study involving 92 SCD patients in a steady state phase was conducted. Blood specimens were obtained for complete blood count (CBC), in conjunction with the identification of IgG for aCL and anti-β2GPI utilizing enzyme-linked immunosorbent assay (ELISA) and the assessment of LA through the Diluted Russell Viper Venom Time (dRVVT). The prevalence of LA, aCL, and anti-β2GPI (IgG) in SCD patients at steady state was 29.4%, 16.3%, and 5.4%, respectively. A correlation was found between LA and chronic leg ulcers, history of thrombosis, decreased platelet counts (PLT), and increased mean platelet volume (MPV) in SCD patients. Furthermore, aCL (IgG) exhibited a significant association with chronic leg ulcers, history of thrombosis, elevated Hemoglobin (Hb) levels, increased red blood cell count (RBC), and higher red cell distribution width (RDW) in SCD patients at steady state phase. This research elucidates the incidence of LA and aCL in SCD patients during steady state, linking these autoantibodies to hematological parameters and clinical complications; thus, prospective assessments of aPL in SCD patients are essential.
- 8 December 2025
- Published by Springer Nature in Thrombosis Journal
- Vol. 23 (1) , 117
Open AccessThe correlation of lupus anticoagulant and anticardiolipin antibodies with hematological parameters and clinical findings in sickle cell disease at steady state phase
Current therapeutic interventions for Sickle Cell Disease (SCD) have improved patient survival; however, the clinical determinants of elevated autoantibody prevalence and related complications in patients with SCD remain insufficiently elucidated. This study aimed to examine the frequency of lupus anticoagulant (LA), anticardiolipin antibody (aCL), and anti-beta2 glycoprotein I antibodies (anti- β2GPI) in patients with SCD at steady state phase to evaluate their possible correlations with hematological factors and clinical complications. This cross-sectional study involving 92 SCD patients in a steady state phase was conducted. Blood specimens were obtained for complete blood count (CBC), in conjunction with the identification of IgG for aCL and anti-β2GPI utilizing enzyme-linked immunosorbent assay (ELISA) and the assessment of LA through the Diluted Russell Viper Venom Time (dRVVT). The prevalence of LA, aCL, and anti-β2GPI (IgG) in SCD patients at steady state was 29.4%, 16.3%, and 5.4%, respectively. A correlation was found between LA and chronic leg ulcers, history of thrombosis, decreased platelet counts (PLT), and increased mean platelet volume (MPV) in SCD patients. Furthermore, aCL (IgG) exhibited a significant association with chronic leg ulcers, history of thrombosis, elevated Hemoglobin (Hb) levels, increased red blood cell count (RBC), and higher red cell distribution width (RDW) in SCD patients at steady state phase. This research elucidates the incidence of LA and aCL in SCD patients during steady state, linking these autoantibodies to hematological parameters and clinical complications; thus, prospective assessments of aPL in SCD patients are essential.
- Open Access
- 1 December 2025
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 18, 4767-4768
Can routine hematological markers improve obesity risk stratification? A translational comment on El-Aghbary et al. [Response to Letter]
Response to Letter in regards to Can Routine Hematological Markers Improve Obesity Risk Stratification? A Translational Comment on El-Aghbary et al [Letter]
- 1 December 2025
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 18, 4767-4768
Open AccessCan routine hematological markers improve obesity risk stratification? A translational comment on El-Aghbary et al. [Response to Letter]
Response to Letter in regards to Can Routine Hematological Markers Improve Obesity Risk Stratification? A Translational Comment on El-Aghbary et al [Letter]
- 4 September 2025
- Published by Springer Nature in Aerobiologia
- Vol. 41 (4) , 777-786
Aeroallergen sensitization patterns among allergic respiratory diseases patients living in Sana’a City, Yemen
- 4 September 2025
- Published by Springer Nature in Aerobiologia
- Vol. 41 (4) , 777-786
Aeroallergen sensitization patterns among allergic respiratory diseases patients living in Sana’a City, Yemen
- Open Access
- 1 September 2025
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 18, 3403-3414
Exploring the Relationship Between Inflammatory Biomarkers and Anthropometric Measures of Obesity in Healthy Adults: A Case Control Study
Background: Obesity is a critical public health issue, marked by an accumulation of adipose tissue that presents numerous health hazards, with recent focus on the link between obesity and inflammation, especially in the context of inflammatory biomarkers as indicators of metabolic abnormalities related to obesity. Objective: This study aimed to investigate the correlation between inflammatory biomarkers such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and hematological indicators of inflammation with anthropometric obesity measures in obese and non-obese healthy adults. Methods: The study employed a case control design involving both obese and non-obese healthy adults. The research evaluated anthropometric indicators. Blood samples were collected from participants to measure complete blood count (CBC), CRP and ESR. Platelet /Lymphocyte ratio (PLR), Neutrophil/Lymphocyte ratio (NLR), Monocyte/Lymphocyte ratio (MLR), and the systemic immune-inflammation index (SII) were calculated. Results: A significant association exists between familial obesity, lack of physical activity, and constipation persistence in obese individuals compared to non-obese individuals. In the obese cohort, mean values of white blood cells (TWBCs), neutrophils, monocytes, platelet count, NLR, PLR, MLR, and SII were elevated compared to the non-obese group. Statistically significant differences in ESR and CRP were noted between the two populations. A positive correlation exists between TWBCs and WHR, whereas lymphocytes correlate positively with WHR and negatively with body fat percentage. Eosinophils exhibited negative associations with obesity metrics, while ESR and CRP had significant positive correlations with obesity indicators like BMI and body fat percentage; PLR showed a negative relationship with WHR and a positive one with body fat percentage, lacking significant correlations with BMI, WC, HC, or abdominal obesity. Conclusion: The research indicates significant elevations in hematological biomarkers among obese individuals, highlighting a probable link between obesity and inflammation, with specific inflammatory markers potentially serving as predictors of obesity-related health risks.
- 1 September 2025
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 18, 3403-3414
Open AccessExploring the Relationship Between Inflammatory Biomarkers and Anthropometric Measures of Obesity in Healthy Adults: A Case Control Study
Background: Obesity is a critical public health issue, marked by an accumulation of adipose tissue that presents numerous health hazards, with recent focus on the link between obesity and inflammation, especially in the context of inflammatory biomarkers as indicators of metabolic abnormalities related to obesity. Objective: This study aimed to investigate the correlation between inflammatory biomarkers such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and hematological indicators of inflammation with anthropometric obesity measures in obese and non-obese healthy adults. Methods: The study employed a case control design involving both obese and non-obese healthy adults. The research evaluated anthropometric indicators. Blood samples were collected from participants to measure complete blood count (CBC), CRP and ESR. Platelet /Lymphocyte ratio (PLR), Neutrophil/Lymphocyte ratio (NLR), Monocyte/Lymphocyte ratio (MLR), and the systemic immune-inflammation index (SII) were calculated. Results: A significant association exists between familial obesity, lack of physical activity, and constipation persistence in obese individuals compared to non-obese individuals. In the obese cohort, mean values of white blood cells (TWBCs), neutrophils, monocytes, platelet count, NLR, PLR, MLR, and SII were elevated compared to the non-obese group. Statistically significant differences in ESR and CRP were noted between the two populations. A positive correlation exists between TWBCs and WHR, whereas lymphocytes correlate positively with WHR and negatively with body fat percentage. Eosinophils exhibited negative associations with obesity metrics, while ESR and CRP had significant positive correlations with obesity indicators like BMI and body fat percentage; PLR showed a negative relationship with WHR and a positive one with body fat percentage, lacking significant correlations with BMI, WC, HC, or abdominal obesity. Conclusion: The research indicates significant elevations in hematological biomarkers among obese individuals, highlighting a probable link between obesity and inflammation, with specific inflammatory markers potentially serving as predictors of obesity-related health risks.
- 30 June 2025
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 42 (3) , 867-874
The Correlation of Anti-phospholipid Antibodies, Anti-cyclic Citrullinated Peptide Antibody, Anti-nuclear Antibodies with Hematological Inflammatory Markers and Clinical Manifestations in Sickle Cell Disease During Steady State Phase
Despite the documented presence of anti-phospholipid antibodies (aPL) and autoantibodies in certain cohorts of sickle cell disease (SCD) patients, the clinical risk factors associated with their development and subsequent complications remain inadequately elucidated. This study aims to investigate the seroprevalence of aPL, anti-cyclic citrullinated peptide antibody (anti-CCP) and anti-nuclear antibodies (ANA), along with their correlation with hematological, inflammatory markers and clinical findings in patients SCD during steady state phase. This cross-sectional study involved 92 SCD patients, employing an automated hematology autoanalyzer for complete blood count alongside evaluating of inflammatory markers. aPL (IgM and IgG) and anti-CCP were measured via enzyme-linked immunosorbent assay and ANA tested through indirect immunofluorescence assay. The study revealed a prevalence of 17.4% for aPL (IgG), 13% for aPL (IgM), 41.3% for ANA, and 15.2% for anti-CCP among SCD patients, where aPL (IgG) positive individuals showing lower inflammatory markers and significant associations with chronic leg ulcers and thrombosis history. There was a correlation between anti-CCP positivity and arthritis, while Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio (PLR), and Systemic Immune Inflammation Index showed negative associations with arthritis and a positive relationship between PLR and leg ulcers in SCD patients. The significant seroprevalence of aPL and autoantibodies in SCD patients suggests that integrating immunological, hematological and inflammatory markers could enhance clinical assessments and therapeutic strategies for SCD.
- 30 June 2025
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 42 (3) , 867-874
The Correlation of Anti-phospholipid Antibodies, Anti-cyclic Citrullinated Peptide Antibody, Anti-nuclear Antibodies with Hematological Inflammatory Markers and Clinical Manifestations in Sickle Cell Disease During Steady State Phase
Despite the documented presence of anti-phospholipid antibodies (aPL) and autoantibodies in certain cohorts of sickle cell disease (SCD) patients, the clinical risk factors associated with their development and subsequent complications remain inadequately elucidated. This study aims to investigate the seroprevalence of aPL, anti-cyclic citrullinated peptide antibody (anti-CCP) and anti-nuclear antibodies (ANA), along with their correlation with hematological, inflammatory markers and clinical findings in patients SCD during steady state phase. This cross-sectional study involved 92 SCD patients, employing an automated hematology autoanalyzer for complete blood count alongside evaluating of inflammatory markers. aPL (IgM and IgG) and anti-CCP were measured via enzyme-linked immunosorbent assay and ANA tested through indirect immunofluorescence assay. The study revealed a prevalence of 17.4% for aPL (IgG), 13% for aPL (IgM), 41.3% for ANA, and 15.2% for anti-CCP among SCD patients, where aPL (IgG) positive individuals showing lower inflammatory markers and significant associations with chronic leg ulcers and thrombosis history. There was a correlation between anti-CCP positivity and arthritis, while Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio (PLR), and Systemic Immune Inflammation Index showed negative associations with arthritis and a positive relationship between PLR and leg ulcers in SCD patients. The significant seroprevalence of aPL and autoantibodies in SCD patients suggests that integrating immunological, hematological and inflammatory markers could enhance clinical assessments and therapeutic strategies for SCD.
- Open Access
- 26 May 2025
- Published by Science Publishing Group in Science Journal of Clinical Medicine
- Vol. 14 (2) , 20-26
Impact of Benzene Exposure on Hematological Parameters in Workers: A Comparative Cross-sectional Study with Healthy Non-Exposed Controls in Sudan
Benzene toxicity can lead to a range of serious health impairments, including various forms of anemia and several types of cancer, such as multiple myeloma, lymphoma, and leukemia. It is crucial to minimize exposure to benzene in industrial and environmental settings to protect public health and prevent these potentially life-threatening conditions. To investigate the potential impact of benzene exposure on the hematological profile of workers and to compare the results with those of a healthy, non-exposed population. A comparative cross-sectional study was conducted from July to November 2022 with Benzene workers at the Kosti benzene stations in Sudan were divided into two groups for a study: an exposure group consisting of eighty-seven individuals who were exposed to benzene, and an unexposed group of eighty-seven individuals who had no exposure. Blood samples were collected from all participants in Ethylene Diamine Tetra Acetic Acid (EDTA) tubes for Complete Blood Count (CBC) analysis. The results indicated that the mean values for Red Blood Cells (RBCs) count were significantly higher in the exposure group compared to the control group. Similarly, the lymphocyte count showed a significant increase in the exposure group versus the control group (P<0.001). Additionally, the Mean Cell Hemoglobin Concentration (MCHC) was also significantly elevated in the exposed individuals compared to the healthy participants (P<0.001). Conversely, the mean values for Mean Cell Volume (MCV) were significantly lower in the exposure group compared to the control group. Hemoglobin (Hb) levels were also significantly reduced in the exposed group versus the control group (P<0.001). The packed cell volume (PCV) was lower in the exposure group compared to the control (P<0.001). Other hematological significant decreases were observed in Mean Cell Hemoglobin (MCH), Neutrophil count, Monocyte count and Platelet (PLTs) count (P < 0.001). No significant differences were found in the mean values of Total White Blood Cells (TWBCs) count and Eosinophil count between the exposed and non-exposed groups. This analytical comparative study highlights the substantial influence of benzene exposure on the hematological parameters of Sudanese workers, indicating notable disparities in hematological variables, thus emphasizing the need for occupational exposure monitoring and protective strategies for benzine workers.
- 26 May 2025
- Published by Science Publishing Group in Science Journal of Clinical Medicine
- Vol. 14 (2) , 20-26
Open AccessImpact of Benzene Exposure on Hematological Parameters in Workers: A Comparative Cross-sectional Study with Healthy Non-Exposed Controls in Sudan
Benzene toxicity can lead to a range of serious health impairments, including various forms of anemia and several types of cancer, such as multiple myeloma, lymphoma, and leukemia. It is crucial to minimize exposure to benzene in industrial and environmental settings to protect public health and prevent these potentially life-threatening conditions. To investigate the potential impact of benzene exposure on the hematological profile of workers and to compare the results with those of a healthy, non-exposed population. A comparative cross-sectional study was conducted from July to November 2022 with Benzene workers at the Kosti benzene stations in Sudan were divided into two groups for a study: an exposure group consisting of eighty-seven individuals who were exposed to benzene, and an unexposed group of eighty-seven individuals who had no exposure. Blood samples were collected from all participants in Ethylene Diamine Tetra Acetic Acid (EDTA) tubes for Complete Blood Count (CBC) analysis. The results indicated that the mean values for Red Blood Cells (RBCs) count were significantly higher in the exposure group compared to the control group. Similarly, the lymphocyte count showed a significant increase in the exposure group versus the control group (P<0.001). Additionally, the Mean Cell Hemoglobin Concentration (MCHC) was also significantly elevated in the exposed individuals compared to the healthy participants (P<0.001). Conversely, the mean values for Mean Cell Volume (MCV) were significantly lower in the exposure group compared to the control group. Hemoglobin (Hb) levels were also significantly reduced in the exposed group versus the control group (P<0.001). The packed cell volume (PCV) was lower in the exposure group compared to the control (P<0.001). Other hematological significant decreases were observed in Mean Cell Hemoglobin (MCH), Neutrophil count, Monocyte count and Platelet (PLTs) count (P < 0.001). No significant differences were found in the mean values of Total White Blood Cells (TWBCs) count and Eosinophil count between the exposed and non-exposed groups. This analytical comparative study highlights the substantial influence of benzene exposure on the hematological parameters of Sudanese workers, indicating notable disparities in hematological variables, thus emphasizing the need for occupational exposure monitoring and protective strategies for benzine workers.
- Open Access
- 9 May 2025
- Published by Science Publishing Group in International Journal of Medical Case Reports
- Vol. 4 (2) , 31-36
COVID-19 and Coagulation Profile: A Retrospective Case Control Study
The COVID-19 virus can initiate a coagulation cascade leading to clot formation and disseminated intravascular coagulation (DIC), raising alarms among healthcare professionals about managing severe cases and underscoring the need for a comprehensive understanding of its mechanisms and therapeutic strategies. This study examines the coagulation parameters and D-Dimer levels in confirmed COVID-19 patients in contrast healthy controls. A retrospective case control study was conducted at the Riyadh Regional Laboratory Centre in Saudi Arabia, involving 384 confirmed COVID-19 patients and an equivalent control group of non-COVID-19 individuals matched for age, gender and nationality/ethnicity. Data on demographics and laboratory results were extracted from electronic medical records. A comparative examination of coagulation factors utilizing standard methodologies for D-Dimer, Prothrombin Time (PT), activated Partial Thromboplastin Time (APTT) and International Normalized Ratio (INR) levels was conducted between individuals diagnosed with nasopharyngeal swab samples by real time- polymerase chain reaction (RT-PCR) from COVID-19 patients and non-COVID-19 individuals. Our study indicated a significant increase in the mean values of PT, APTT and D-dimer in COVID-19 positive patients than non-COVID-19 individuals. Conversely, the mean values of INR were markedly reduced in COVID-19 positive patients compared to non-COVID-19 individuals. COVID-19 patients exhibit significant abnormalities in blood coagulation profile relative to non-COVID-19 individuals. The research indicates that elevated levels of D-Dimer, PT, and APTT may serve as indicators of disease severity and prognostic markers in COVID-19 patients.
- 9 May 2025
- Published by Science Publishing Group in International Journal of Medical Case Reports
- Vol. 4 (2) , 31-36
Open AccessCOVID-19 and Coagulation Profile: A Retrospective Case Control Study
The COVID-19 virus can initiate a coagulation cascade leading to clot formation and disseminated intravascular coagulation (DIC), raising alarms among healthcare professionals about managing severe cases and underscoring the need for a comprehensive understanding of its mechanisms and therapeutic strategies. This study examines the coagulation parameters and D-Dimer levels in confirmed COVID-19 patients in contrast healthy controls. A retrospective case control study was conducted at the Riyadh Regional Laboratory Centre in Saudi Arabia, involving 384 confirmed COVID-19 patients and an equivalent control group of non-COVID-19 individuals matched for age, gender and nationality/ethnicity. Data on demographics and laboratory results were extracted from electronic medical records. A comparative examination of coagulation factors utilizing standard methodologies for D-Dimer, Prothrombin Time (PT), activated Partial Thromboplastin Time (APTT) and International Normalized Ratio (INR) levels was conducted between individuals diagnosed with nasopharyngeal swab samples by real time- polymerase chain reaction (RT-PCR) from COVID-19 patients and non-COVID-19 individuals. Our study indicated a significant increase in the mean values of PT, APTT and D-dimer in COVID-19 positive patients than non-COVID-19 individuals. Conversely, the mean values of INR were markedly reduced in COVID-19 positive patients compared to non-COVID-19 individuals. COVID-19 patients exhibit significant abnormalities in blood coagulation profile relative to non-COVID-19 individuals. The research indicates that elevated levels of D-Dimer, PT, and APTT may serve as indicators of disease severity and prognostic markers in COVID-19 patients.
- Open Access
- 17 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13493
The Influence of Genetic Polymorphisms in Cytochrome P450 (CYP1A1 and 2D6) Gene on the Susceptibility to Philadelphia Negative Chronic Myeloid Leukemia in Sudanese Patients
The most frequent type of leukemia in Africa is chronic myeloid leukemia (CML). The genetic background of the rarer Philadelphia chromosome (Ph) Ph-ve (BCR-ABL-ve) subform of CML is largely unknown in African patients. Therefore, in this study, we aimed to investigate the role of CYP1A1 and 2D6 SNPs in the pathogenesis of Ph-ve CML in the Sudanese population. A total of 126 patients were selected for analysis. DNA was isolated from Ph-ve CML patients and a control group for PCR-RFLP analysis of SNPs CYP1A1*2C and CYP2D6*4. The CYP1A1 gene significantly expressed the GG variant genotype (p < 0.05) in 23.1% of the Ph-ve CML patients and 8% of the control group. In contrast, the CYP2D6 GA genotype was strongly associated with a reduced risk of developing Ph-ve CML (p < 0.005) with a frequency of 50% in Ph-ve patients and 93% in the control group. CYP1A1 GG polymorphism was prevalent among patients with Ph-ve CML, suggesting its role in disease development. CYP2D6 GA (IM) polymorphism was uncommon among patients, compared with the control group, possibly indicating a protective role of the polymorphisms from Ph-ve CML. This study demonstrates an association between key metabolic SNPs and Ph-ve CML and highlights the role that altered xenobiotic metabolism may play in the development of several human leukemias.
- 17 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13493
Open AccessThe Influence of Genetic Polymorphisms in Cytochrome P450 (CYP1A1 and 2D6) Gene on the Susceptibility to Philadelphia Negative Chronic Myeloid Leukemia in Sudanese Patients
The most frequent type of leukemia in Africa is chronic myeloid leukemia (CML). The genetic background of the rarer Philadelphia chromosome (Ph) Ph-ve (BCR-ABL-ve) subform of CML is largely unknown in African patients. Therefore, in this study, we aimed to investigate the role of CYP1A1 and 2D6 SNPs in the pathogenesis of Ph-ve CML in the Sudanese population. A total of 126 patients were selected for analysis. DNA was isolated from Ph-ve CML patients and a control group for PCR-RFLP analysis of SNPs CYP1A1*2C and CYP2D6*4. The CYP1A1 gene significantly expressed the GG variant genotype (p < 0.05) in 23.1% of the Ph-ve CML patients and 8% of the control group. In contrast, the CYP2D6 GA genotype was strongly associated with a reduced risk of developing Ph-ve CML (p < 0.005) with a frequency of 50% in Ph-ve patients and 93% in the control group. CYP1A1 GG polymorphism was prevalent among patients with Ph-ve CML, suggesting its role in disease development. CYP2D6 GA (IM) polymorphism was uncommon among patients, compared with the control group, possibly indicating a protective role of the polymorphisms from Ph-ve CML. This study demonstrates an association between key metabolic SNPs and Ph-ve CML and highlights the role that altered xenobiotic metabolism may play in the development of several human leukemias.